Addendum – Quality (chemistry and manufacturing) Guidance: Questions and Answers
Related guides
Related acts and regulations
From Health Canada
Overview
The purpose of the guidance document is to outline the Quality technical requirements and to assist submission sponsors in preparing the New Drug Submission or Abbreviated New Drug Submission to ensure an effective and efficient assessment process. It can also be used as guidance on the requirements for related drug submissions [for example (e.g.), Supplemental New Drug Submissions (SNDSs), Supplemental Abbreviated New Drug Submissions (SANDSs), Post-Notice of Compliance (NOC) Changes].
In this guide
Download PDF (254 KB, 10 pages)
Details and history
Published: |
October 30, 2017 |
Updated: |
July 1, 2018 |
Part of topic(s): |
For assistance
Contact us by mail:
Bureau of Pharmaceutical Sciences (BPS)
Therapeutic Products Directorate
Health Products and Food Branch
Address Locator: 0201D
Health Canada
Ottawa, Ontario
K1A 0K9
By E-mail: bps_enquiries_enquetes_bsp@hc-sc.gc.ca
By Telephone: 613-946-6829
By Fax: 613-941-0571
Page details
- Date modified: